Clinical Trials Directory

Trials / Completed

CompletedNCT04635293

Preoperative Infusion of Levosimendan in Patients Undergoing Cardiac Surgery

Preoperative Infusion of Levosimendan in High Risk Cardiac Surgery Patients: A Retrospective Study

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
100 (actual)
Sponsor
Aretaieion University Hospital · Academic / Other
Sex
All
Age
18 Years – 75 Years
Healthy volunteers
Not accepted

Summary

The aim of this retrospective study will be to investigate the effect of the preoperative administration of levosimendan on the outcome of patients with compromised cardiac function undergoing cardiac surgery

Detailed description

Patients with severely reduced left ventricular ejection fraction (LVEF) face a high risk of morbidity and mortality after cardiac surgery. Impaired cardiac function preoperatively predisposes patients to low cardiac output syndrome. Levosimendan acts by a different mechanism than traditional inotropes and its preoperative use could improve the outcome of patients with cardiac failure. Specifically, it promotes vasodilation of coronary, pulmonary and systemic vessels, has an anti-inflammatory and anti-oxidant effect and enhances cardiac contractility by improving the response of the myofilaments to intracellular calcium. The aim of this retrospective study will be to investigate the effect of the preoperative administration of levosimendan on the outcome of patients with compromised cardiac function undergoing cardiac surgery.

Conditions

Interventions

TypeNameDescription
PROCEDUREpreoperative infusion of levosimendanthe study group will consist of patients who have received a continuous infusion of levosimendan 0.1 μg/kg/min for 24 hours before cardiac surgery
PROCEDUREno preoperative infusion of levosimendanthe control group will consist of patients who proceeded to the cardiac operation without any infusion for 24 hours preoperatively

Timeline

Start date
2012-01-01
Primary completion
2020-11-09
Completion
2020-11-09
First posted
2020-11-19
Last updated
2020-11-19

Locations

1 site across 1 country: Greece

Source: ClinicalTrials.gov record NCT04635293. Inclusion in this directory is not an endorsement.